Clear Creek Financial Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Clear Creek Financial Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,686	Closed	-$482K	–	289
2020 Q2	$482K	Buy	+8,686	New	+$372K	0.12%	119

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Clear Creek Financial Management's HZNP Position: Q3 2020 in Review

Clear Creek Financial Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2020, closing a stake of 8,686 shares — an estimated $482K sold.

Clear Creek Financial Management first reported a position in HZNP in Q2 2020 and held it in 1 quarter. The position peaked at $482K in Q2 2020. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

Clear Creek Financial Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2020 after selling out during the quarter.
Clear Creek Financial Management sold 8,686 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $482K.
Clear Creek Financial Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 1 quarter.
Clear Creek Financial Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $482K in Q2 2020.
433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on Clear Creek Financial Management's 13F filing for Q3 2020, filed 10 Nov 2020.